Modulation of dendritic cell alternative activation and function by the vitamin A metabolite retinoic acid by Jones, Lucy H et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Modulation of dendritic cell alternative activation and function by
the vitamin A metabolite retinoic acid
Citation for published version:
Jones, LH, Cook, PC, Ivens, AC, Thomas, GD, Phythian-Adams, AT, Allen, JE & MacDonald, AS 2015,
'Modulation of dendritic cell alternative activation and function by the vitamin A metabolite retinoic acid'
International immunology. DOI: 10.1093/intimm/dxv020
Digital Object Identifier (DOI):
10.1093/intimm/dxv020
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
International immunology
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
International Immunology
doi:10.1093/intimm/dxv020
© The Author 2015. Published by Oxford University Press on behalf 
of The Japanese Society for Immunology.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 
License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted reuse, 
distribution, and reproduction in any medium, provided the original work is properly cited.
S
H
O
R
T
  
C
O
M
M
U
N
IC
A
T
IO
N
Modulation of dendritic cell alternative activation and 
function by the vitamin A metabolite retinoic acid
Lucy H. Jones1, Peter C. Cook2, Alasdair C. Ivens1, Graham, D. Thomas1,3,  
Alexander T. Phythian-Adams2, Judith E. Allen1 and Andrew S. MacDonald2 
1Institute of Immunology and Infection Research, Centre for Immunity, Infection and Evolution, School of Biological Sciences, 
University of Edinburgh, Scotland, UK
2Manchester Collaborative Centre for Inflammation Research, Faculty of Life Sciences, University of Manchester, Manchester 
M13 9NT, UK
3Present address: La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA.
Correspondence to: A. S. MacDonald; E-mail: andrew.macdonald@manchester.ac.uk
Received 5 March 2015, accepted 15 April 2015
Abstract
The archetypal Th2 cytokine IL-4 has previously been shown to alternatively activate murine 
macrophages and, more recently, dendritic cells (DCs) both in vitro and in vivo. IL-4 has also been 
shown to induce Aldh1a2 (aldehyde dehydrogenase 1a2) expression in murine macrophages recruited 
to the peritoneal cavity. However, the influence of IL-4 on DC Aldh1a2 induction in vivo has not yet 
been addressed. In this work, we found that DCs show enhanced aldehyde dehydrogenase enzyme 
activity in vivo, which led us to investigate the impact of the vitamin A metabolite all-trans retinoic 
acid (RA) on DC alternative activation and function. Antagonism of RA receptors reduced production 
of resistin-like molecule alpha by DCs responding to IL-4, while addition of exogenous RA enhanced 
production of this marker of alternative activation. Functionally, RA increased DC induction of CD4+ 
T-cell IL-10, while reducing CD4+ T-cell IL-4 and IL-13, revealing a previously unidentified role for RA in 
regulating the ability of alternatively activated DCs to influence Th2 polarization.
Keywords: APC, IL-4, Th2
Introduction
The importance of vitamin A  (Retinol) signalling within the 
immune system has been established during the past dec-
ade and highlighted recently by work indicating that retinoic 
acid (RA), the transcriptionally active metabolite of vitamin A, 
is involved in the development and promotion of CD4+ T-cell 
responses (1–3). RA expression by gut-associated dendritic 
cells (DCs) imprints intestinal specificity on T cells (2, 4, 5), and 
mucosal CD103+ DCs have been shown to express Aldh1a2 
(aldehyde dehydrogenase 1a2; RALDH), a Retinol metaboliz-
ing enzyme (3), and promote extra-thymic conversion of naive 
T cells into Foxp3+ regulatory T cells (3, 6). Additionally, it is 
becoming clear that vitamin A signalling is required for T helper 
cell function beyond the promotion of FoxP3 expression (7–10).
IL-4 has been shown to alter DC cytokine production and 
modulate their capacity to polarize naive T cells (11–15). 
Further, IL-4 responsiveness is known to be required for opti-
mal DC polarization of CD4+ T cells, as IL-4Rα-deficient DCs 
are less competent inducers of T-cell IL-10, IL-17 and IFNγ 
(15). In addition, DCs undergo a programme of alternative 
activation in response to IL-4, characterized by high-level 
production of the resistin-like molecule alpha (RELMα) (15, 
16). Expression of RELMα by alternatively activated DCs 
(AADCs) during Th2 priming regulates IFNγ and IL-4 and pro-
motes IL-10 and IL-13 secretion by CD4+ T cells (15). IL-4 
can also induce DC Aldh1a2 expression/aldehyde dehydro-
genase activity (17–19), and it has recently been suggested 
that there is interplay between RA and IL-4 in DC expression 
of Arg1 (20), Aldh1a2 and induction of Foxp3+ Tregs in the 
context of experimental autoimmune encephalomyelitis (19). 
However, crosstalk between RA and IL-4 in the process of DC 
alternative activation, and how this may affect Th2 polariza-
tion, has not yet been addressed.
In this study, we have investigated the combined impact of 
RA and IL-4 on DC alternative activation and function. We first 
assessed the influence of IL-4 on the mRNA profile of murine 
bone marrow-derived DCs (BMDCs) in vitro and found that 
this resulted in significantly altered expression of 109 genes, 
with Aldh1a2 being among 21 genes up-regulated >2-fold 
following exposure to IL-4. Aldehyde dehydrogenase activity 
was also induced in DCs, but not macrophages, following in 
 International Immunology Advance Access published May 11, 2015
 at Edinburgh U
niversity on July 13, 2015
http://intim
m
.oxfordjournals.org/
D
ow
nloaded from
 
Page 2 of 8  RA influences alternative activation of dendritic cells
vivo delivery of IL-4. Importantly, we reveal that RA promotes 
DC RELMα production and regulates the ability of AADCs to 
support Th2 cell polarization. Taken together, our data provide 
compelling evidence that concurrent exposure to IL-4 and RA 
results in phenotypic and functional changes in DCs, in par-
ticular modifying their capacity to polarize CD4+ T cells.
Methods
Mice
C57BL/6, BALB/c, IL-10eGFP (21) and 4get (22) (IL-4GFP; 
BALB/c) mice were maintained at the University of Edinburgh. 
All experiments were approved under a Project License 
granted by the Home Office (UK) and conducted in accord-
ance with local guidelines.
In vivo IL-4c
C57BL/6 female mice were injected intra-peritoneally with PBS 
or IL-4 complex (IL-4c) that is composed of rIL-4 (Peprotech, 
UK) complexed at a 1:5 molar ratio with anti-IL-4 antibody 
(Clone 11B11, BioXcell, Malaysia). Mice received 0.1, 0.5 or 
1 μg of IL-4 and cells were harvested 6 h later.
DC culture
BMDCs were generated with 20-ng ml−1 recombinant granulo-
cyte macrophage colony-stimulating factor (rGM-CSF) as pre-
viously described (23), with the omission of 2-mercaptoethanol. 
Following 10 days of culture, immature cells were cultured for 
a final 6 or 18 h with or without rIL-4 (20 ng ml−1; Peprotech), 
all-trans RA reconstituted in DMSO (RA; 10 μM, Sigma, UK) 
or LE540 (10 μM, WAKO, Japan) reconstituted in DMSO, and 
cRPMI-1640 containing 5-ng ml−1 rGM-CSF (Peprotech).
RNA extraction and Illumina BeadChip arrays
RNA was extracted from cells using TRIzol or Pure Link RNA 
Mini Kit and DNase-treated according to the manufacturer’s 
instructions (Life Technologies, UK). RNA was converted to 
cDNA using Superscript-III (Invitrogen, UK). Quantitative 
PCR was performed using SYBR Green mastermix-II (Roche, 
UK) and a Roche Light Cycler 480, using primers previ-
ously documented (15) with the exception of Aldh1a2F:5′-
CATGGTATCCTCCGCAATG-3′ and Aldh1a2R:5′GCGCAT
TTAAGGCATTGTAAC-3′. To assess DC gene expression, 
RNA was labelled using the TotalPrep RNA Amplification kit 
(Life Technologies) and hybridized to Illumina MouseWG-6 
BeadChip arrays (MouseWG6_V2_0_R3_11278593_A, each 
comprising 45 281 features), according to the manufacturer’s 
instructions. Three biological replicates were carried out for 
wild-type (WT) DCs. All analyses were conducted in R using 
Bioconductor packages (www.r-project.org; www.bioconduc-
tor.org). A total of six arrays were quality controlled (QC) ana-
lysed using the arrayQualityMetrics package in Bioconductor 
(24, 25). Raw data from arrays that passed QC were trans-
formed using a variance-stabilizing transformation method 
prior to normalization across all arrays using the robust 
spline normalization method, using the lumi package in 
Bioconductor. Pairwise group comparisons were undertaken 
using linear modelling. Subsequently, empirical Bayesian 
analysis was applied, including vertical (within a given com-
parison) P value adjustment for multiple testing, which con-
trols for false discovery rate, using the limma Bioconductor 
package (25). The data discussed in this publication have 
been deposited in NCBI’s Gene Expression Omnibus (26) 
and are accessible through GEO Series accession num-
ber GSE59868 (http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?acc=GSE59868).
Aldefluor assay
For select experiments, the aldefluor assay (Stemcell 
Technologies) was performed, following surface staining, 
essentially as in manufacturer’s instructions.
Flow cytometry
BMDCs described in Fig. 2 were flow sorted based on CD11c 
and aldefluor activity using a BD FACS Aria-II. Spleen and 
lymph node suspensions from 4Get [IL-4eGFP (22)] or TIGR 
[IL-10eGFP (21)] mice were sorted as green fluorescent pro-
tein (GFP)−CD4+ using a BD FACS Aria-II. peritoneal exudate 
cells were stained directly ex vivo, essentially as in (15). 
Samples were acquired using an LSR II or FACS Canto II flow 
cytometer, using BD FACS Diva software and analysed with 
FlowJo v.9 software (Tree Star, Inc., USA).
RELMα and Ym1 intracellular staining
Cells were surface stained and washed prior to fixation using 
2% formaldehyde, permeabilized on ice for 20 min using 
1× Permeabilization buffer (BD Bioscience) prior to primary 
antibody staining using polyclonal rabbit antibodies against 
murine RELMα (Peprotech) and biotinylated polyclonal goat 
IgG against murine Ym1/ECF-L (R&D Systems). The Zenon 
Rabbit IgG labelling kit (Life Technologies) was used to 
detect bound anti-RELMα, and Streptavidin-allophycocyanin 
was used to detect bound anti-Ym1Biotin (eBioscience) (15).
DC:T-cell co-culture
Fifty thousand sorted IL10-eGFP−CD4+ or 4get−CD4+ were cul-
tured with 2500 BMDCs, with 1-μg ml−1 anti-CD3 (clone 145-2C11 
produced in house) with or without IL-4 (20 ng ml−1; Peprotech) 
and RA (10 μM; Sigma) in cRPMI-1640. Cells were cultured at 
37°C in a humidified atmosphere of 5% CO2 for 4 days.
ELISA
Cytokine ELISAs were performed on culture supernatants 
using paired mAb purified in house, or purchased from eBio-
science, BD Pharmingen or R&D Systems (UK), and recom-
binant cytokine standards purchased from Peprotech. Ym1 
ELISAs were performed using a DuoSet ELISA kit (R&D 
Systems), RELMα ELISAs were performed using paired rab-
bit anti-murine RELMα antibodies (Peprotech) and standards 
were made using recombinant murine RELMα (Peprotech).
Statistical analyses
Statistical analyses were carried out using GraphPad Prism 
5 software one-way analysis of variance with Dunnett’s 
post-test or Student’s t-tests were employed to determine 
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significant differences between groups: *P < 0.05, **P < 0.01, 
***P < 0.001, ****P < 0.0001.
Results and Discussion
IL-4 enhances DC aldehyde dehydrogenase activity and 
RELMα protein expression in vitro and in vivo
WT DCs were cultured in vitro with rIL-4, RNA extracted and an 
Illumina mRNA expression array carried out (Supplementary 
Figure  1, available at International Immunology Online). 
Upon KEGG enrichment, the pathway with which the IL-4-
induced gene profile most closely associated was ‘metabolic 
pathways’, in which 14 genes were significantly increased 
(Supplementary Table 1, available at International Immunology 
Online). In order to determine genes that may have more prom-
inent roles in modulating cellular function following exposure 
to IL-4, we chose to use a 2-fold change (2FC) cut-off, focus-
ing only on significantly altered transcripts (adjP = <0.05) that 
doubled in expression in response to IL-4 (Supplementary 
Figure  1B, available at International Immunology Online). 
When using this level of stringency, only two metabolic genes 
remained: Ak2 (adenylate kinase 2), a mitochondrial protein 
(27), and Aldh1a2 (Supplementary Figure  1C, available at 
International Immunology Online). In keeping with our previ-
ous identification of the ability of IL-4 to alternatively activate 
DCs (15), the genes for Ccl24, Chi3l3, Chi3l4 and Retnla were 
all significantly up-regulated >2FC within the 6-h IL-4-treated 
BMDC microarray (Supplementary Figure  1C, available at 
International Immunology Online), whereas Arg1 was not sig-
nificantly altered (adjP = <0.05) at any fold cut-off.
Confirming our mRNA expression array data (Supplementary 
Figure  1, available at International Immunology Online), in 
vitro culture of DCs with rIL-4 resulted in significant enhance-
ment of Aldh1a2 transcript, as measured by quantitative PCR 
(Fig. 1A). Furthermore, enhanced Aldh1a2 transcription fol-
lowing IL-4 exposure correlated with increased DC aldehyde 
dehydrogenase activity (28) (Fig.  1B), as has been sug-
gested previously (17–19).
Next, to determine the impact of IL-4 on DC retinoid metab-
olism in vivo, we injected IL-4c (29) into the peritoneal cavity 
of C57BL/6 mice and assessed DC aldehyde dehydrogenase 
activity (Fig. 1C). Peritoneal DCs, defined as SiglecF−B220− 
Ly6C−Ly6G−F4/80−CD11c+MHCIIhi (Fig.  1C), displayed 
aldehyde dehydrogenase activity (Fig. 1D) in an IL-4c dose-
dependent manner. This was in contrast to resident mac-
rophages of the peritoneal cavity (Fig.  1D), which failed to 
increase aldehyde dehydrogenase activity in response to 
IL-4c treatment (30). We then used flow cytometric cell sort-
ing based on aldefluor activity (Fig. 2A) to confirm that IL-4-
exposed DCs possessing aldehyde dehydrogenase activity 
expressed high levels of Aldh1a2 (Fig.  2B). Furthermore, 
IL-4-exposed aldefluor positive DCs also expressed high lev-
els of Retnla (Fig. 2C). However, in contrast to Retnla, alde-
hyde dehydrogenase activity inversely correlated with Chi3l3 
expression (Fig.  2D). These results reveal IL-4-dependent 
induction of aldehyde dehydrogenase activity in DCs in vivo 
(Fig. 1C), confirming our in vitro data (Fig. 1) and previous in 
vitro reports (17–19, 31). Further, these results also show that 
IL-4 can induce aldehyde dehydrogenase activity and Retnla 
expression within the same DC population (Fig. 2).
Enhanced expression of RALDH2, MHC-II and CD206 in 
myeloid cells of monocytic but not tissue resident origin has 
recently been shown (30). Our new data suggest that within a 
population of DCs, a spectrum of expression of such markers 
can occur, as DCs sorted as being aldefluor positive showed 
reduced expression of Chi3l3 (and Mrc1, data not shown) 
compared with their aldefluor negative counterparts (Fig. 2). 
Furthermore, understanding the interaction between RA and 
IL-4 in cells of myeloid origin is extremely timely given the 
recent report that RA controls the tissue-specific localization 
of peritoneal macrophages (32), and our data that IL-4 drives 
a program of proliferation within macrophages of the same 
tissue site (33).
Inhibition of retinoic acid receptors reduces IL-4-
dependent RELMα production by DCs
To begin to understand the interaction between alternative 
activation and retinoid metabolism in DCs, we used the pan 
retinoic acid receptor (RAR) antagonist LE540 (34) to inhibit 
RAR function. DCs were cultured simultaneously with LE540 
and IL-4 and their alternative activation status assessed by 
intracellular staining (Fig.  3A and B) and ELISA (Fig.  3C). 
In comparison with cells that were not treated with the RAR 
antagonist, LE540 limited IL-4 induction of intracellular 
RELMα protein (Fig. 3A and B) and reduced RELMα secre-
tion by DCs (Fig. 3C). Again, in contrast to RELMα, LE540 did 
not impair intracellular or secreted Ym1/2 in DCs treated with 
IL-4 (Fig. 3A–C).
Having identified that RA signalling enhanced DC RELMα 
production, we next wanted to directly address whether RA was 
able to promote RELMα production in the context of IL-4. To test 
this, we exposed DCs to exogenous RA either alone or in the 
presence of IL-4 and assessed levels of intracellular (Fig. 3D 
and E) and secreted (Fig. 3F) RELMα and Ym1/2. The addi-
tion of RA alone had no significant impact on DC expression of 
the alternative activation markers RELMα or Ym1/2 (Fig. 3D–F). 
However, culture with both RA and IL-4 resulted in a signifi-
cantly higher proportion of DCs that synthesized (Fig. 3D and 
E) and secreted (Fig. 3F) RELMα protein than those exposed 
to IL-4 alone. In contrast, exogenous RA did not significantly 
alter DC production of Ym1/2 (Fig. 3D–F). Taken together, these 
data indicate that retinoid availability influences the alterna-
tive activation profile of DCs. Exogenous RA, likely acting via 
RARs, was able to enhance IL-4-induced RELMα, whereas 
exogenous RA had no significant impact on DC Ym1 capacity 
(Fig. 3). Thus, our data support a central role for RA and RAR 
signalling in RELMα, but not Ym1/2, production by AADCs.
RA signals via binding to heterodimeric nuclear hormone 
receptors of the RAR or retinoic X receptor (RXR) families 
(35). Ligand-bound RAR/RXRs associate with RA response 
elements in the promoter regions of target genes to mediate 
their downstream effects (36). Although RARα is the domi-
nant RAR isoform in myeloid cells (37), all RAR isoforms have 
been detected in murine splenic DCs (38) and RARβ has 
recently been shown to interact with the Il4ra promoter (19). 
One hypothesis to explain the ability of exogenous RA or inhi-
bition of RAR signalling to differentially influence RELMα and 
Ym1/2 (Fig. 3) is that different nuclear pairings of RARs (α, β, 
γ)/RXRs may be responsible for controlling distinct aspects 
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of the profile of alternative activation that is initiated by IL-4 
in DCs.
Up-regulation of RELMα but not Ym1/2 in the presence of 
RA, a molecule known to be involved in induction of immune 
regulation/tolerance (1), is consistent with the putative func-
tions of these two molecules. Ym1 is thought to be pro-inflam-
matory, forming epithelial damage-associated crystals in the 
lung (39), causing neutrophilic inflammation during nema-
tode infection (40) and increasing in response to stab wound-
ing or chemical-induced seizure in the brain (41). In contrast, 
RELMα can be described as a regulatory molecule, having 
been shown to limit pulmonary inflammation (42) and pro-
mote IL-10 secretion (15). RA may thus be able to fine-tune 
AADC function at sites of inflammation by enhancing IL-4-
driven regulatory, but not inflammatory, molecules.
RA and IL-4 alter T-cell polarization by DCs
Previous studies have suggested that RA can directly influ-
ence CD4+ T-cell polarization, by promoting IL-4 secretion 
under Th2 conditions (43, 44) or limiting IFNγ from already 
polarized Th1 cells (45). However, these early reports did 
not assess the influence of RA on T cells in the presence 
of DCs. As RA and IL-4 enhanced DC RELMα production 
(Fig. 3), and we have previously shown that Retnla−/− DCs 
display impaired ability to induce CD4+ T-cell IL-10 and 
IL-13 secretion (15), we investigated the induction of Th2 
cytokines by DCs exposed simultaneously to RA and IL-4 
(Fig.  4). DC:T-cell co-culture assays incorporating 4Get 
[IL-4eGFP (22)] or TIGR [IL-10eGFP (21)] reporter T cells 
and WT DCs allowed us to determine if DCs exposed to 
RA and IL-4 had an altered capacity to polarize polyclonally 
activated T cells (Fig.  4). In agreement with our previous 
work (15), IL-4 enhanced DC induction of CD4+ T-cell IL-10, 
as assessed by GFP expression and IL-10 protein secretion 
(Fig. 4). Notably, while IL-10 levels increased further upon 
simultaneous addition of RA (Fig. 4A–C), the addition of RA 
reduced Il4 mRNA transcription in CD4+ T cells, as assessed 
by GFP expression (Fig. 4B). Due to the exogenous recom-
binant IL-4 in this system, it was not possible to accurately 
measure T-cell IL-4 secretion. However, RA exerted a simi-
lar regulatory effect on the ability of DCs to support T-cell 
IL-13 production, with significantly reduced IL-13 secretion 
Fig. 1. IL-4 induces aldehyde dehydrogenase activity and alternative activation in DCs in vitro and in vivo. BMDCs were cultured overnight with 
20-ng ml−1 IL-4 (A and B) and expression of Aldh1a2 (A) and aldehyde dehydrogenase activity (B) assessed. IL-4c (doses as described in figure) 
was injected intra-peritoneally. Peritoneal exudate cells were harvested 6 h later, DCs were defined as SiglecF−B220−Ly6C−Ly6G−F4/80−CD11c+
MHCIIhi and macrophages as SiglecF−B220−Ly6C−Ly6G−F4/80+ (C). Aldehyde dehydrogenase activity of DC and macrophage populations was 
assessed ex vivo (D). Data in A and B are representative of five independent experiments, error bars represent triplicate culture wells. Data points 
in (D) and (E) represent individual mice, pooled from three independent experiments n = 10–11 per group. **P < 0.01, ***P < 0.001.
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Fig. 2. IL-4-induced DC aldehyde dehydrogenase activity correlates with expression of RELMα but not Ym1. Following overnight culture with 
IL-4, BMDC populations were sorted by flow cytometry based upon aldefluor activity (A) and quantitative PCR was used to assess expression 
of Aldh1a2 (B), Retnla (C) and Chi3l3 (D). Data are representative of 4–5 independent experiments. Error bars represent triplicate culture wells, 
a.u. = arbitrary units as compared with Hprt expression. **P < 0.01.
Fig. 3. RAR signalling regulates IL-4-driven DC alternative activation. BMDCs were cultured overnight with or without 20-ng ml−1 IL-4 and either 
the pan RAR antagonist LE540 (A–C), RA (D–F) or vehicle control. RELMα and Ym1/2 protein production was assessed by intracellular staining 
(A and D), while RELMα and Ym1/2 secretion was assessed by ELISA (C and F). Data are representative of 3 (A–C) and >5 (D–F) independent 
experiments. Error bars represent triplicate culture wells. *P < 0.05, **P < 0.01, ****P < 0.0001.
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following addition of RA along with IL-4, as compared with 
IL-4 alone (Fig. 4D). These data strongly suggest that, in the 
context of RA, AADCs have a modified ability to promote Th2 
effector responses, with RA altering the profile of respond-
ing CD4+ T cells such that they produce lower levels of IL-4 
and IL-13, and increased IL-10.
Although we cannot exclude the possibility that part of 
the impact of RA in these experiments may be through its 
direct action on responding T cells, our novel data indicat-
ing that vitamin A metabolites alter DC ability to promote or 
inhibit several key facets of Th2 cytokine production (Fig. 4) 
are supported by a recent report where DCs isolated from 
vitamin A-deficient animals were shown to induce higher lev-
els of CD4+ T-cell IL-13 in a partially IL-6-dependent manner 
(10). Our data are also consistent with a recent study showing 
that the immune system can act as a sensor of malnutrition, 
promoting the secretion of IL-13 from ILC2s in the absence 
of sufficient RA (46). Our work reveals that DCs exposed 
to both RA and IL-4 express increased levels of RELMα, 
as compared with IL-4 alone (Fig. 3). Since we have previ-
ously shown that RELMα regulates CD4+ T-cell responses 
via the promotion of IL-13 and IL-10 and the inhibition of 
IL-4 (15), we anticipated that we would see an increase in 
both IL-10 and IL-13, and reduced IL-4 secretion, by T cells 
stimulated in the presence of DCs, RA and IL-4. In keeping 
with this hypothesis, T-cell transcription of IL-4 decreased 
and production of IL-10 increased following co-culture with 
RA-treated AADCs (Fig. 4A–C). However, contrary to expec-
tation, IL-13 was found to decrease in the presence of both 
RA and IL-4 (Fig. 4D), revealing an additional role for RA in 
IL-13 inhibition. In our hands, IL-4 and RA down-regulated 
DC secretion of IL-6 (data not shown), which may contribute 
to reduced T-cell IL-13 production upon co-culture, as block-
ing IL-6 in CD8α−CD11b+CD103− MLN DC:T-cell cultures has 
been shown to limit IL-13 secretion (10). These data raise the 
interesting possibility that the balance of alternative activation 
products such as RELMα, with vitamin A metabolites such as 
RA, can significantly influence the functional capacity of DCs 
to polarize T cells.
This work elevates current understanding of the impact of 
environmental mediators on DC activation and function, in 
particular highlighting the singular and collective influence of 
RA and IL-4 over DC alternative activation and ability to direct 
Th2 responses. These findings may be particularly relevant 
when considering that countries with high levels of dietary 
vitamin A deficiency are also regions in which type-2 infec-
tions are prevalent (47).
Supplementary data
Supplementary data are available at International Immunology 
Online.
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